GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (OTCPK:ESALF) » Definitions » Cyclically Adjusted Revenue per Share

Eisai Co (Eisai Co) Cyclically Adjusted Revenue per Share : $52.23 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Eisai Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Eisai Co's adjusted revenue per share for the three months ended in Dec. 2023 was $4.303. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $52.23 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Eisai Co's average Cyclically Adjusted Revenue Growth Rate was -1.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -1.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Eisai Co was -0.70% per year. The lowest was -3.00% per year. And the median was -1.80% per year.

As of today (2024-04-29), Eisai Co's current stock price is $40.005. Eisai Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $52.23. Eisai Co's Cyclically Adjusted PS Ratio of today is 0.77.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Eisai Co was 1.54. The lowest was 0.64. And the median was 0.91.


Eisai Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Eisai Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Cyclically Adjusted Revenue per Share Chart

Eisai Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 66.50 64.33 75.46 61.95 58.30

Eisai Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.65 58.30 53.49 50.60 52.23

Competitive Comparison of Eisai Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eisai Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Eisai Co's Cyclically Adjusted PS Ratio falls into.



Eisai Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eisai Co's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=4.303/106.8000*106.8000
=4.303

Current CPI (Dec. 2023) = 106.8000.

Eisai Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 21.044 95.700 23.485
201406 18.224 98.000 19.860
201409 17.706 98.500 19.198
201412 16.316 97.900 17.799
201503 16.236 97.900 17.712
201506 15.719 98.400 17.061
201509 15.840 98.500 17.175
201512 17.329 98.100 18.866
201603 15.011 97.900 16.376
201606 18.172 98.100 19.784
201609 18.242 98.000 19.880
201612 16.773 98.400 18.205
201703 16.061 98.100 17.485
201706 17.861 98.500 19.366
201709 18.053 98.800 19.515
201712 19.132 99.400 20.556
201803 21.121 99.200 22.739
201806 19.438 99.200 20.927
201809 19.524 99.900 20.873
201812 19.539 99.700 20.930
201903 22.019 99.700 23.587
201906 19.882 99.800 21.277
201909 18.852 100.100 20.114
201912 23.891 100.500 25.389
202003 27.127 100.300 28.885
202006 21.472 99.900 22.955
202009 20.012 99.900 21.394
202012 24.367 99.300 26.207
202103 18.945 99.900 20.254
202106 6.301 99.500 6.763
202109 20.700 100.100 22.086
202112 6.220 100.100 6.636
202203 5.615 101.100 5.932
202206 4.796 101.800 5.032
202209 4.243 103.100 4.395
202212 4.848 104.100 4.974
202303 5.170 104.400 5.289
202306 4.859 105.200 4.933
202309 4.165 106.200 4.189
202312 4.303 106.800 4.303

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Eisai Co  (OTCPK:ESALF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Eisai Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=40.005/52.23
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Eisai Co was 1.54. The lowest was 0.64. And the median was 0.91.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Eisai Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Eisai Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Eisai Co (Eisai Co) Business Description

Industry
Traded in Other Exchanges
Address
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.